FrancophonIA/ELRC3.0 huggingface dataset:
English: If a dose is missed the patient should take Xarelto immediately and continue on the following day with the once daily intake as recommended.
Danish: Hvis patienten kommer til at springe en dosis Xarelto over, skal pågældende tage denne dosis øjeblikkeligt og fortsætte næste dag med den anbefalede daglige dosis.
English: Safety and efficacy of Xarelto have not been studied in patients with prosthetic heart valves; therefore, there are no data to support that Xarelto provides adequate anticoagulation in this patient population.
Danish: Der foreligger derfor ingen data, der kan dokumentere, at Xarelto giver tilstrækkelig antikoagulation for denne patientpopulation.
English: HR (95% CI) p-value b)
Danish: HR (95% KI) p-værdi b)
English: Each 20 mg film-coated tablet contains 20 mg rivaroxaban.
Danish: Hver 20 mg filmovertrukket tablet indeholder 20 mg rivaroxaban.
English: (See section 4.4 for haemodynamically unstable PE patients.)
Danish: 4.4 vedrørende hæmodynamisk ustabile patienter med lungeemboli).
English: Major bleeding events a) Rivaroxaban 15 mg twice daily for 3 weeks followed by 20 mg once daily b) Enoxaparin for at least 5 days, overlapped with and followed by VKA * p < 0.0001 (non-inferiority to a prespecified HR of 1.75); HR: 0.886 (0.661
Danish: Rivaroxaban 15 mg to gange dagligt i tre uger efterfulgt af 20 mg én gang dagligt b) Enoxaparin i mindst 5 dage, overlappende med og efterfulgt af VKA * p < 0,0001 (non-inferioritet i forhold til en forudspecificeret HR på 1,75); HR: 0,886
English: Due dates
Danish: 3 UDLØBSDATO
English: After the administration of crushed Xarelto 15 mg or 20 mg film-coated tablets, the dose should then be immediately followed by enteral feeding (see section 5.2).
Danish: Administration af knuste Xarelto 15 mg eller 20 mg filmovertrukne tabletter skal straks efterfølges af enteral ernæring (se pkt.
English: Haemorrhagic risk
Danish: Hazard ratio
English: Xarelto 15 mg tablets Xarelto 20 mg tablets rivaroxaban
Danish: Xarelto 15 mg tabletter Xarelto 20 mg tabletter rivaroxaban
English: - allergic reactions, including allergic skin reactions - impaired function of the liver (may be seen in tests performed by your doctor) - blood tests may show an increase in bilirubin, some pancreatic or liver enzymes or in the number of platelets - fainting - feeling unwell - faster heartbeat - dry mouth - hives
Danish: Blodpladerne hjælper med at stoppe blødning allergiske reaktioner, herunder allergiske hudreaktioner nedsat leverfunktion (kan ses i blodprøver) stigning i bilirubin, visse bugspytkirtel- og leverenzymer eller antal blodplader påvist ved blodprøver.
English: Xarelto is to be used with caution in patients with creatinine clearance 15 - 29 ml/min (see section 4.4).
Danish: Xarelto skal bruges med forsigtighed til patienter med en kreatininclearance på 15 - 29 ml/min (se pkt.
English: Within the highest tertile according to centre, the HR with rivaroxaban versus warfarin was 0.69 (95% CI: 0.35 - 1.35).
Danish: I henhold til center var HR med rivaroxaban i forhold til warfarin i den højeste tertil 0,69 (95 % KI: 0,35 - 1,35).
English: Within the highest tertile according to centre, the HR with rivaroxaban versus warfarin was 0.642 (95% CI: 0.277 - 1.484).
Danish: I henhold til center var HR med rivaroxaban i forhold til warfarin i den højeste tertil (0,642 (95% KI: 0,277 - 1,484).
English: Safety and efficacy of Xarelto have not been established in breast-feeding women.
Danish: Xareltos sikkerhed og virkning hos ammende kvinder er ikke klarlagt.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS UNIT DOSE BLISTER (10 x 1 TABLETS) FOR 2.5 MG
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP ENKELTDOSIS BLISTER (10 X 1 TABLETTER) FOR 2,5 MG
English: OUTER CARTON AND LABEL FOR HDPE BOTTLE FOR 20 MG
Danish: YDRE KARTON OG ETIKET TIL HDPE-BEHOLDER FOR 20 MG
English: Hepatic disease associated with coagulopathy and clinically relevant bleeding risk including cirrhotic patients with Child Pugh B and C (see section 5.2).
Danish: Leversygdom, som er forbundet med koagulationsdefekt og klinisk relevant blødningsrisiko, herunder cirrosepatienter med Child-Pugh B og C (se pkt.
English: Each film-coated tablet contains 2.5 mg rivaroxaban.
Danish: Hver filmovertrukken tablet indeholder 2,5 mg rivaroxaban.
English: Xarelto 2.5mg bid + ASA 100mg od: 5.2 (4.7 - 5.8)
Danish: Kaplan-Meier-estimater (%) efter 30 måneder: Xarelto 2,5 mg to gange dagligt + ASA 100 mg én gang dagligt: 5,2 (4,7
English: Day 1 to 21: One 15 mg tablet twice a day (one 15 mg tablet in the morning and one in the evening) together with food.
Danish: Dag 1 til 21: Én 15 mg-tablet to gange dagligt (én 15 mg tablet morgen og én tablet aften) sammen med mad.
English: In the Einstein Choice study (see Table 8) Xarelto 20 mg and 10 mg were both superior to 100 mg acetylsalicylic acid for the primary efficacy outcome.
Danish: I Einstein Choice-studiet (se tabel 8) var både Xarelto 20 mg og 10 mg superior sammenlignet med 100 mg acetylsalicylsyre med hensyn til det primære effektendepunkt.
English: 12.6% of patients 2.1% of patients
Danish: 12,6 % af patienterne
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON FOR 10 MG
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON FOR 10 MG
English: Xarelto may be increased.
Danish: Xarelto, da Xareltos virkning kan blive forstærket.
English: Xarelto 2.5 mg tablets rivaroxaban
Danish: Xarelto 2,5 mg tabletter rivaroxaban
English: Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery
Danish: Forebyggelse af venøs tromboemboli (VTE) hos voksne patienter, der gennemgår planlagt hofteleds- eller knæledsalloplastik
English: In the Einstein Choice study (see Table 10) Xarelto 20 mg and 10 mg were both superior to 100 mg acetylsalicylic acid for the primary efficacy outcome.
Danish: I Einstein Choice-studiet (se tabel 10) var både Xarelto 20 mg og 10 mg superior sammenlignet med 100 mg acetylsalicylsyre med hensyn til det primære effektendepunkt.
English: Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.
Danish: Forebyggelse af venøs tromboemboli (VTE) hos voksne patienter, som gennemgår planlagt hofteledseller knæledsalloplastik.
English: - if you are allergic to rivaroxaban or any of the other ingredients of this medicine (listed in section 6) - if you are bleeding excessively - if you have a disease or condition in an organ of the body that increases the risk of serious bleeding (e.g. stomach ulcer, injury or bleeding in the brain, recent surgery of the brain or eyes) - if you are taking medicines to prevent blood clotting (e.g. warfarin, dabigatran, apixaban or heparin), except when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open - if you have an acute coronary syndrome and previously had a bleeding or a blood clot in your brain (stroke) - if you have coronary artery disease or peripheral artery disease and previously had a bleeding in your brain (stroke) or where there was a blockage of the small arteries providing blood to the brain's deep tissues (lacunar stroke) or if you had a blood clot in your brain (ischaemic, nonlacunar stroke) in the previous month - if you have a liver disease which leads to an increased risk of bleeding - if you are pregnant or breast-feeding
Danish: - hvis du bløder kraftigt - hvis du har en sygdom eller tilstand i et af kroppens organer, som øger risikoen for alvorlig blødning (f.eks. mavesår, hjerneskade eller -blødning, nylig operation i hjernen eller øjnene) - hvis du tager medicin for at hindre blodpropper (f.eks. warfarin, dabigatran, apixaban eller heparin), bortset fra når du skifter blodfortyndende behandling, eller hvis du får heparin gennem et vene- eller arteriekateter for at holde det åbent - hvis du får et akut koronarsyndrom og tidligere har haft en blødning eller blodprop i hjernen (slagtilfælde) - hvis du har en koronararteriesygdom eller perifer arteriesygdom eller tidligere havde en hjerneblødning (apopleksi), eller hvor der var en blokering af de små arterier, der forsyner hjernens dybtliggende væv med blod (lakunær apopleksi), eller hvis du havde en blodprop i hjernen (iskæmisk,ikke-lakunær apopleksi) inden for den sidste måned - hvis du har en leversygdom, der medfører øget risiko for blødning - hvis du er gravid eller ammer.
English: ITT analyses of efficacy in patients with non-valvular atrial fibrillation
Danish: Studiepopulation ITT-analyser af virkningen hos patienter med ikke-valvulær atrieflimren
English: Xarelto 15 mg tablets rivaroxaban
Danish: Xarelto 15 mg tabletter rivaroxaban
English: ▪ some medicines for treatment of epilepsy (phenytoin, carbamazepine, phenobarbital) ▪ St John's Wort (Hypericum perforatum), a herbal product used for depression ▪ rifampicin, an antibiotic
Danish: ● visse former for medicin til behandling af epilepsi (phenytoin, carbamazepin, phenobarbital)
English: The COMMANDER HF study included 5,022 patients with heart failure and significant coronary artery disease (CAD) following a hospitalization of decompensated heart failure (HF) which were randomly assigned into one of the two treatment groups: rivaroxaban 2.5 mg twice daily (N=2,507) or matching placebo (N=2,515), respectively.
Danish: COMMANDER HF studiet inkluderede 5.022 patienter med hjertesvigt og signifikant koronararteriesygdom (CAD) efter en indlæggelse af dekompenseret hjertesvigt (HF).
English: XARELTO 2.5 mg twice daily Placebo
Danish: XARELTO 2,5 mg to gange dagligt + ASA 100 mg én gang dagligt
English: Each tablet contains 15 mg or 20 mg of rivaroxaban, respectively.
Danish: Hver tablet indeholder henholdsvis 15 mg eller 20 mg rivaroxaban.
English: In Einstein PE, 4,832 patients with acute PE were studied for the treatment of PE and the prevention of recurrent DVT and PE.
Danish: I Einstein PE blev 4.832 patienter med akut PE undersøgt for behandling af PE og forebyggelse af recidiverende DVT og PE. Behandlingsvarigheden var 3, 6 eller 12 måneder afhængigt af investigators kliniske vurdering.
English: In the Einstein Choice study (Table 9) Xarelto 20 mg and 10 mg were both superior to 100 mg acetylsalicylic acid for the primary efficacy outcome.
Danish: I Einstein Choice-studiet (se tabel 9) var både Xarelto 20 mg og 10 mg superior sammenlignet med 100 mg acetylsalicylsyre med hensyn til det primære effektendepunkt.
English: In patients receiving rivaroxaban for treatment of DVT and PE and prevention of recurrence, the 5/95 percentiles for PT (Neoplastin) 2 - 4 hours after tablet intake (i.e. at the time of maximum effect) for 15 mg rivaroxaban twice daily ranged from 17 to 32 s and for 20 mg rivaroxaban once daily from 15 to 30 s. At trough (8 - 16 h after tablet intake) the 5/95 percentiles for 15 mg twice daily ranged from 14 to 24 s and for 20 mg once daily (18 - 30 h after tablet intake) from 13 to 20 s. In patients with non-valvular atrial fibrillation receiving rivaroxaban for the prevention of stroke and systemic embolism, the 5/95 percentiles for PT (Neoplastin) 1 - 4 hours after tablet intake (i.e. at the time of maximum effect) in patients treated with 20 mg once daily ranged from 14 to 40 s and in patients with moderate renal impairment treated with 15 mg once daily from 10 to 50 s. At trough (16 - 36 h after tablet intake) the 5/95 percentiles in patients treated with 20 mg once daily ranged from 12 to 26 s and in patients with moderate renal impairment treated with 15 mg once daily from 12 to 26 s.
Danish: Hos patienter med ikke-valvulær atrieflimren i behandling med rivaroxaban for forebyggelse af apopleksi og systemisk emboli var 5/95-percentilerne for PT (Neoplastin) 1 - 4 timer efter tabletindtagelse (dvs. på tidspunktet for maksimal effekt) hos patienter behandlet med 20 mg én gang dagligt fra 14-40 sek., og hos patienter med moderat nyreinsufficiens behandlet med 15 mg én gang dagligt fra 10-50 sek. Ved dalniveau (16 - 36 timer efter tabletindtagelse) var 5/95 percentilerne hos patienter behandlet med 20 mg én gang dagligt fra 12-26 sek., og hos patienter med moderat nyreinsufficiens behandlet med 15 mg én gang dagligt fra 12-26 sek.
English: 5 mg or 10 mg respectively, co-administered with either ASA or ASA plus clopidogrel or ticlopidine
Danish: Henholdsvis 5 mg eller 10 mg administreret sammen med enten acetylsalicylsyre eller acetylsalicylsyre plus clopidogrel eller ticlopidin
English: In the enoxaparin/VKA group, there was no clear relation between the level of mean centre TTR (Time in Target INR Range of 2.0 - 3.0) in the equally sized tertiles and the incidence of the recurrent VTE (p=0.082 for interaction).
Danish: I enoxaparin/VKA-gruppen var der ingen klar sammenhæng mellem niveauet for middel center-TTR (tid i target INR-niveauet på 2,0 - 3,0) i de lige store tertiler og forekomsten af recidiverende VTE (p = 0,082 for interaktion).
English: HR (95% CI) p-value
Danish: HR (95 % KI) p-værdi
English: Xarelto contains the active substance rivaroxaban and is used in adults to: - treat blood clots in the veins of your legs (deep vein thrombosis) and in the blood vessels of your lungs (pulmonary embolism), and to prevent blood clots from re-occurring in the blood vessels of your legs and/or lungs.
Danish: Xarelto indeholder det aktive stof rivaroxaban og benyttes hos voksne til: - behandling af blodpropper i venerne i benene (dyb venetrombose) og i blodkarrene i lungerne
English: Xarelto 2.5 mg film-coated tablets
Danish: Xarelto 2,5 mg filmovertrukne tabletter
English: Each 15 mg film-coated tablet contains 15 mg rivaroxaban.
Danish: Hver 15 mg filmovertrukket tablet indeholder 15 mg rivaroxaban.
English: 1.6% of patients
Danish: 2,1 % af patienterne
English: Take Xarelto on a regular basis and for as long as your doctor keeps prescribing it. Do not stop taking Xarelto without talking to your doctor first.
Danish: Tag Xarelto regelmæssigt og så længe, som din læge ordinerer det til dig.
English: Xarelto 10 mg tablets rivaroxaban
Danish: Xarelto 10 mg tabletter rivaroxaban
English: Prevention of atherothrombotic events in patients with CAD/PAD
Danish: Forebyggelse af aterotrombotiske hændelser hos patienter med koronararteriesygdom (CAD) /perifer arteriesygdom (PAD)
English: Gender No dose adjustment (see section 5.2)
Danish: Køn Ingen dosisjustering (se pkt.
English: Xarelto 20 mg tablets rivaroxaban
Danish: Xarelto 20 mg tabletter rivaroxaban
English: The prespecified net clinical benefit (primary efficacy outcome plus major bleeding events) was reported with a HR of 0.849 ((95% CI: 0.633 - 1.139), nominal p value p= 0.275).
Danish: Den forudspecificerede kliniske nettofordel (primært effektendepunkt plus større blødning) blev indberettet med en HR på 0,849 ((95 % KI: 0,633-1,139), nominel p-værdi p=0,275).
English: Enoxaparin/VKAb) 3, 6 or 12 months N=4,131
Danish: Enoxaparin/VKAb) 3, 6 eller 12 måneder N=4.131
English: OUTER CARTON AND LABEL FOR HDPE BOTTLE FOR 10 MG
Danish: YDRE KARTON OG ETIKET TIL HDPE-BEHOLDER FOR 10 MG
English: Xarelto 2.5 mg (only applicable for outer carton, not applicable for bottle label)
Danish: Xarelto 2,5 mg (gælder kun ydre emballage, gælder ikke etiket på plastbeholder)
English: OUTER CARTON AND LABEL FOR HDPE BOTTLE FOR 15 MG
Danish: YDRE KARTON OG ETIKET TIL HDPE-BEHOLDER FOR 15 MG
English: Non-major clinically relevant bleeding events
Danish: Klinisk relevant mindre blødning
English: In patients receiving rivaroxaban for treatment of acute DVT 20 mg once daily the geometric mean concentration (90% prediction interval) 2 - 4 h and about 24 h after dose (roughly representing maximum and minimum concentrations during the dose interval) was 215 (22 - 535) and 32 (6239) mcg/l, respectively.
Danish: Hos patienter, der fik rivaroxaban 20 mg én gang dagligt til behandling af akut dyb venetrombose (DVT), var den geometriske middelkoncentration (90 % prediction-interval) 2 - 4 timer og ca. 24 timer efter administration henholdsvis 215 (22 - 535) og 32 (6 - 239) µg/l, hvilket stort set svarer til maksimums- og minimumskoncentrationerne i doseringsintervallet.
English: - if you have an increased risk of bleeding, as could be the case in situations such as: severe kidney disease, since your kidney function may affect the amount of medicine that works in your body if you are taking other medicines to prevent blood clotting (e.g. warfarin, dabigatran, apixaban or heparin), when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open (see section “Other medicines and Xarelto”) bleeding disorders very high blood pressure, not controlled by medical treatment diseases of your stomach or bowel that might result in bleeding, e.g. inflammation of the bowels or stomach, or inflammation of the oesophagus (gullet), e.g. due to gastroesophageal reflux disease (disease where stomach acid goes upwards into the oesophagus) a problem with the blood vessels in the back of your eyes (retinopathy) a lung disease where your bronchi are widened and filled with pus (bronchiectasis), or previous bleeding from your lung you are older than 75 years you weigh 60 kg or less you have a coronary artery disease with severe symptomatic heart failure - if you have a prosthetic heart valve - if you know that you have a disease called antiphospholipid syndrome (a disorder of the immune system that causes an increased risk of blood clots), tell your doctor who will decide if the treatment may need to be changed.
Danish: Vær ekstra forsigtig med at tage Xarelto hvis du har øget risiko for blødning, som f.eks. i følgende situationer: svær nyresygdom, da din nyrefunktion kan påvirke den mængde lægemiddel, der virker i kroppen hvis du tager anden medicin for at forebygge blodpropper (f.eks. warfarin, dabigatran, apixaban eller heparin), når du skifter blodfortyndende behandling, eller hvis du får heparin gennem et vene- eller arteriekateter for at holde det åbent (se punktet "Brug af anden medicin sammen med Xarelto") blødningsforstyrrelser meget højt blodtryk, som ikke er reguleret med medicin sygdomme i mave eller tarm, der kan give blødninger, f.eks. betændelse i tarmene eller i maven eller irritation i spiserøret f.eks. på grund af sure opstød (sygdom, hvor mavesyren kommer op i spiserøret) et problem med blodkarrene bagerst i øjnene (retinopati) en lungesygdom, hvor dine bronkier er udvidede og fyldt med pus (bronkiektase), eller du tidligere har haft blødning fra lungerne du er over 75 år du vejer 60 kg eller derunder du har koronararteriesygdom med alvorlig symptomatisk hjertesvigt - hvis du har en kunstig hjerteklap.
English: Titanium dioxide (E 171) Iron oxide red (E 172)
Danish: Hypromellose 2910 Titandioxid (E 171) Rød jernoxid (E 172)
English: This Xarelto 15 mg and 20 mg treatment initiation pack is only for the first 4 weeks of treatment.
Danish: Denne Xarelto 15 mg og 20 mg startpakning er kun beregnet til de første 4 ugers behandling Når du har taget startpakken, vil behandlingen fortsætte med Xarelto 20 mg én gange dagligt, som din læge har fortalt dig.
English: Xarelto 20 mg film-coated tablets
Danish: Xarelto 20 mg filmovertrukne tabletter
English: Prevention of VTE in adult patients undergoing elective hip or knee replacement surgery
Danish: Forebyggelse af VTE hos voksne patienter, der gennemgår planlagt hofteleds- eller knæledsalloplastik
English: How much to take
Danish: Hvis du tager
English: In patients with moderate renal impairment (creatinine clearance 30 - 49 ml/min) concomitantly receiving other medicinal products which increase rivaroxaban plasma concentrations Xarelto is to be used with caution (see section 4.5).
Danish: Xarelto anvendes med forsigtighed hos patienter med moderat nedsat nyrefunktion (kreatininclearance 30 - 49 ml/min), som samtidig behandles med andre lægemidler, der øger plasmakoncentrationen af rivaroxaban (se pkt.
English: Xarelto is contraindicated in patients with hepatic disease associated with coagulopathy and clinically relevant bleeding risk, including cirrhotic patients with Child Pugh B and C (see section 4.3).
Danish: Xarelto er kontraindiceret hos patienter med leversygdom, der er forbundet med koagulationsdefekt og en klinisk relevant blødningsrisiko, herunder cirrosepatienter med Child-Pugh B og C (se pkt.
English: Xarelto 10 mg film-coated tablets
Danish: Xarelto 10 mg filmovertrukne tabletter
English: They come - in blisters in cartons of 14, 20, 28, 30, 56, 60, 98, 168 or 196 film-coated tablets or - in unit dose blisters in cartons of 10 x 1 or 100 x 1 or - in multipacks comprising 10 cartons, each containing 10 x 1 film-coated tablets or - in bottles of 100 film-coated tablets.
Danish: De fås - i blisterpakninger i æsker med 14, 20, 28, 30, 56, 60, 98, 168 eller 196 filmovertrukne tabletter eller - i enkeltdosisblisterpakninger i æsker med 10 × 1 eller 100 × 1, eller - i multipakker med 10 æsker, der hver indeholder 10 x 1 filmovertrukne tabletter eller - i plastbeholdere med 100 filmovertrukne tabletter.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER OF 10 TABLETS FOR 2.5 MG
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP BLISTER MED 10 TABLETTER FOR 2,5 MG
English: Uncommon (may affect up to 1 in 100 people) - bleeding into the brain or inside the skull - bleeding into a joint causing pain and swelling - thrombocytopenia (low number of platelets, which are cells that help blood to clot)
Danish: Ikke almindelige bivirkninger (forekommer hos op til 1 ud af 100 behandlede) blødning i hjernen eller i kraniet blødning i led, så der opstår smerter og hævelse nedsat antal blodplader (trombocytopeni).
English: Xarelto 15 mg film-coated tablets
Danish: Xarelto 15 mg filmovertrukne tabletter
English: 06803 Bitterfeld-Wolfen
Danish: Ortsteil Greppin, Salegaster Chaussee 1 06803 Bitterfeld-Wolfen
English: • bronchiectasis or history of pulmonary bleeding
Danish: • bronkiektase eller lungeblødning i anamnesen.
English: 15 mg film-coated tablet: red, round biconvex tablets (6 mm diameter, 9 mm radius of curvature) marked with the BAYER-cross on one side and “15” and a triangle on the other side.
Danish: 15 mg filmovertrukket tablet: Røde, runde bikonvekse tabletter (6 mm diameter, 9 mm krumningsradius) mærket med et Bayer-kors på den ene side og "15" samt en trekant på den anden side.
English: Clarithromycin (500 mg twice a day), for instance, considered as a strong CYP3A4 inhibitor and moderate P-gp inhibitor, led to a 1.5 fold increase in mean rivaroxaban AUC and a 1.4 fold increase in Cmax.
Danish: F.eks. øgede clarithromycin (500 mg to gange dagligt), der betragtes som en stærk hæmmer af CYP3A4 og en moderat hæmmer af P-gp, middel-AUC for rivaroxaban med en faktor 1,5 og Cmax med en faktor 1,4.
English: 40 mg od 12 ± 2 days p Rivaroxaban 10 mg od 12 ± 2 days
Danish: 40 mg enoxa-parin én gang dagligt dage p 10 mg rivaroxaban én gang dagligt dage
English: Xarelto 20 mg film-coated tablets are brown-red, round, biconvex and marked with the BAYER-cross on one side and “20” and a triangle on the other.
Danish: Xarelto 20 mg filmovertrukne tabletter er rødbrune, runde, bikonvekse og mærket med et Bayer-kors på den ene side og "20" samt en trekant på den anden side.
English: Enoxaparin/VKAb) 3, 6 or 12 months N=2,413
Danish: Enoxaparin/VKAb) 3, 6 eller 12 måneder N=2.413
English: In the clinical studies mucosal bleedings (i.e. epistaxis, gingival, gastrointestinal, genito urinary including abnormal vaginal or increased menstrual bleeding) and anaemia were seen more frequently during long term rivaroxaban treatment on top of single or dual anti-platelet therapy.
Danish: I kliniske studier sås slimhindeblødninger (f.eks. blødning fra næse, tandkød, mave-tarm-kanalen, genitalier og urinveje, herunder unormal blødning fra skeden eller øget menstruationsblødning) og anæmi hyppigere under langtidsbehandling med rivaroxaban i tillæg til enkelt eller dobbelt antitrombotisk behandling.